Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Mirati Therapeutics, Inc. Common Stock](/topic/$mrtx)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$ACTU LOOKING PRIMED FOR A BREAKOUT 📈 ACT is pioneering next gen cancer therapy targeting tough to treat tumors with its proprietary drug. Technical View Price holding $XXXX support Higher lows and rising RSI Volume push above 10k could trigger next leg up Price Targets: 🎯 1$8.49 2$9.22 3$11.69 4$13.63 Peers: $MRTX $TERN $CRSP $DNA"  
[X Link](https://x.com/EquityRaven/status/1978457079460344199) [@EquityRaven](/creator/x/EquityRaven) 2025-10-15T13:45Z 1431 followers, XXX engagements


"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"  
[X Link](https://x.com/doepke_michel/status/1977369129972650327) [@doepke_michel](/creator/x/doepke_michel) 2025-10-12T13:41Z 5648 followers, 8266 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Mirati Therapeutics, Inc. Common Stock

Top Social Posts

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$ACTU LOOKING PRIMED FOR A BREAKOUT 📈 ACT is pioneering next gen cancer therapy targeting tough to treat tumors with its proprietary drug. Technical View Price holding $XXXX support Higher lows and rising RSI Volume push above 10k could trigger next leg up Price Targets: 🎯 1$8.49 2$9.22 3$11.69 4$13.63 Peers: $MRTX $TERN $CRSP $DNA"
X Link @EquityRaven 2025-10-15T13:45Z 1431 followers, XXX engagements

"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5648 followers, 8266 engagements

Mirati Therapeutics, Inc. Common Stock (MRTX)
/topic/$mrtx/posts